iSpecimen, a Lexington, Mass.-based provider of on-demand human biospecimens to the life science community, secured $8m in its Series B Financing.
Backers included new investor OneBlood and existing investors.
The company intends to use the funds to grow its healthcare partner network and scale operations.
Founded in 2009 by Christopher Ianelli, MD, PhD, Chief Executive Officer, iSpecimen provides life scientists with a source of high-quality human biospecimens for their research and development programs. The company’s technology allows users to search through patient specimens flowing through its partner network of healthcare facilities to find biospecimens based on associated laboratory and medical record data.
The company simplifies the process of finding the right specimens from specific patient populations by partnering with healthcare providers, gaining access to their laboratory specimens and patient-level data, and matching these against research needs.